ĚěĂŔ´«Ă˝

Feature Channels: Infectious Diseases

Filters close
Released: 26-Apr-2024 12:05 PM EDT
Texas Biomed Researching Vaccines and Treatments for Highly Pathogenic Avian Influenza
Texas Biomedical Research Institute

Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.

Released: 26-Apr-2024 12:00 PM EDT
Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19
World Journal of Stem Cells

Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infection typically presents with fever and respiratory symptoms, which can progress to

25-Apr-2024 12:05 PM EDT
Undocumented Latinx patients got COVID-19 vaccine at same rate as U.S. citizens
University of California, Los Angeles (UCLA), Health Sciences

For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study found.

Released: 26-Apr-2024 10:05 AM EDT
New Tool Helps Identify Babies at High-Risk for RSV
Vanderbilt University Medical Center

A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April), according to Vanderbilt University Medical Center (VUMC) research published in Open Forum Infectious Diseases and to be presented at the American Thoracic Society 2024 International Conference.

18-Apr-2024 4:05 PM EDT
Future Parents More Likely to Get RSV Vaccine When Pregnant if Aware That RSV Can Be a Serious Illness in Infants
Ann and Robert H. Lurie Children's Hospital of Chicago

A nationwide survey of people who were pregnant or trying to become pregnant found that overall 54 percent expressed interest in the RSV vaccine during pregnancy. Perceiving RSV as a serious illness in infants was the strongest predictor of likely vaccination during pregnancy. Likelihood to receive the RSV vaccine during pregnancy was also higher among parents with a child at home already. Findings were published in the journal Pediatrics.

Newswise: Vaccinologists Keith Klugman and Shabir Madhi awarded Sabin’s Prestigious Gold Medal
Released: 23-Apr-2024 3:05 AM EDT
Vaccinologists Keith Klugman and Shabir Madhi awarded Sabin’s Prestigious Gold Medal
University of the Witwatersrand, Johannesburg

The Sabin Vaccine Institute presented the Albert B. Sabin Gold Medal to physician-researchers Keith Klugman and Shabir Madhi.

Released: 22-Apr-2024 9:05 AM EDT
Rise seen in use of antibiotics for conditions they can’t treat – including COVID-19
Michigan Medicine - University of Michigan

America is going the wrong way when it comes to prescribing antibiotics, with 1 in 4 prescriptions going to patients who have conditions that the drugs won’t touch, a new study finds.

Newswise: From ashes to adversity: Lessons from South Australia's business recovery amidst bushfires and pandemic
Released: 15-Apr-2024 9:05 PM EDT
From ashes to adversity: Lessons from South Australia's business recovery amidst bushfires and pandemic
University of South Australia

New research has given insight into the resilience and recovery of businesses in two South Australian regions following a major bushfire event and disruptions caused by the COVID-19 pandemic.

Not for public release

This news release is embargoed until 15-Apr-2024 5:00 PM EDT Released to reporters: 9-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Researchers resolve old mystery of how phages disarm pathogenic bacteria
Released: 15-Apr-2024 8:05 AM EDT
Researchers resolve old mystery of how phages disarm pathogenic bacteria
Texas A&M AgriLife

New study details long-sought mechanisms and structures

Released: 11-Apr-2024 4:05 PM EDT
MSU expert: what to know about avian influenza detections
Michigan State University

Although the current avian influenza outbreak began more than two years ago, detections have been made in recent weeks in cattle, cats and large commercial poultry flocks across the country and in Michigan.

Released: 9-Apr-2024 11:05 AM EDT
HealthTrackRx Appoints Leading Healthcare Expert Dr. Steven Goldberg as Chief Medical Officer
HealthTrackRx

HealthTrackRx, the nation's premier molecular diagnostic testing laboratory, today announced the appointment of Steven Goldberg, MD, MBA, as its Chief Medical Officer (CMO).

3-Apr-2024 2:05 PM EDT
A monoclonal antibody targeting the fusion glycoprotein spike protects against deadly Nipah virus
Uniformed Services University of the Health Sciences (USU)

The humanized monoclonal antibody known as hu1F5, which specifically binds to the fusion (F) glycoprotein of both Nipah virus and Hendra virus and prevents virus infection of cells (neutralizes) has now proven effective in protecting against the often fatal Nipah virus in animal studies.

Newswise: Testing environmental water to monitor COVID-19 spread in unsheltered encampments
29-Mar-2024 8:00 AM EDT
Testing environmental water to monitor COVID-19 spread in unsheltered encampments
American Chemical Society (ACS)

To better understand COVID-19’s spread during the pandemic, public health officials expanded wastewater surveillance. These efforts track SARS-CoV-2 levels and health risks among most people, but they miss people who live without shelter, a population particularly vulnerable to severe infection.

   
Newswise: UC San Diego Receives $6.7M to Develop Whole-Body Inflammation Imaging
Released: 1-Apr-2024 6:05 PM EDT
UC San Diego Receives $6.7M to Develop Whole-Body Inflammation Imaging
University of California San Diego

Researchers at UC San Diego have received new grants that will help develop full-body imaging techniques to detect inflammation, which is currently very difficult to visualize in the clinic.

Not for public release

This news release is embargoed until 1-Apr-2024 5:00 PM EDT Released to reporters: 27-Mar-2024 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Hunting an Underground Epidemic
Released: 1-Apr-2024 2:05 PM EDT
Hunting an Underground Epidemic
University of Utah Health

Valley fever is a fungal respiratory infection that’s stealthily spreading through the soil and dust throughout the American West. An interdisciplinary research team is trying to map where the disease-causing fungus can survive and where it’ll spread as the climate changes.

   
Released: 1-Apr-2024 1:05 PM EDT
Georgia Tech Researchers Develop More Broadly Protective Coronavirus Vaccine
Georgia Institute of Technology

Researchers at the Georgia Institute of Technology and the University of Wisconsin-Madison have developed a new vaccine that offers broad protection against not only SARS-CoV-2 variants, but also other bat sarbecoviruses.

Newswise: Cancer therapies show promise in combating tuberculosis
Released: 25-Mar-2024 3:05 PM EDT
Cancer therapies show promise in combating tuberculosis
University of Notre Dame

A study from the University of Notre Dame, Massachusetts General Hospital and the National Institutes of Health has identified a combination of medications that may improve blood flow within granulomas, benefiting drug delivery.

Newswise: Breakthrough antibiotic shows promise against obstinate mycobacterial infections
Released: 25-Mar-2024 3:05 AM EDT
Breakthrough antibiotic shows promise against obstinate mycobacterial infections
National University of Singapore (NUS)

A team of scientists led by Prof Guillermo Bazan from NUS Institute for Functional Intelligent Materials (I-FIM) has developed a novel antibiotic named COE-PNH2 that is capable of combating hard-to-treat mycobacterial lung infections.

   
Newswise: New vaccine against a highly fatal tropical disease – and potential bioterror weapon – demonstrates efficacy in animal studies
Released: 21-Mar-2024 3:05 PM EDT
New vaccine against a highly fatal tropical disease – and potential bioterror weapon – demonstrates efficacy in animal studies
University of California, Los Angeles (UCLA), Health Sciences

A vaccine against the bacterium that causes melioidosis was highly protective against the disease, which is endemic in many tropical areas, causing approximately 165,000 cases with 89,000 fatalities around the world each year. It is so dangerous that it is categorized as a Tier 1 Select Agent of bioterrorism.

Released: 21-Mar-2024 10:05 AM EDT
Michigan is seeing a rise in measles: MSU experts can comment on related health issues
Michigan State University

Earlier this week, the Centers for Disease Control and Prevention, or CDC, issued an advisory to inform clinicians and public health officials of an increase in global and U.S. measles cases.

Released: 20-Mar-2024 1:05 PM EDT
Experts warn climate change will fuel spread of infectious diseases
UC Davis Health

Infectious diseases specialists call the medical field to be ready to deal with the impact of climate change on spreading diseases, such as malaria, Valley fever, E-coli and Lyme disease.

Released: 19-Mar-2024 3:05 PM EDT
Targeting multiple COVID variants through the twist in the spike protein
University of Michigan

Teardrop-shaped particles designed to inactivate multiple strains of the SARS-CoV-2 virus could one day complement existing treatments for COVID-19, according to a new study led by researchers at the University of Michigan and Jiangnan University in Wuxi, China.

Released: 18-Mar-2024 11:05 AM EDT
Don’t Delay Vaccines—They Are Safe, Effective and Save Lives
Children's Hospital Los Angeles

Vaccine misinformation has gone mainstream—a post-pandemic reality that is putting more children at risk of exposure to potentially serious vaccine-preventable diseases like measles.

Newswise: Mutations do not predict the severity of current variants of SARS-CoV-2
Released: 15-Mar-2024 12:05 PM EDT
Mutations do not predict the severity of current variants of SARS-CoV-2
University of North Carolina at Charlotte

New research from UNC Charlotte’s Center for Computational Intelligence to Predict Health and Environmental Risks has found that the two most prevalent strains of the virus that cause COVID-19, SARS-CoV-2 variants BA.2.86 and JN.1, are not significantly better than their predecessor Omicron at evading immune responses and causing infections despite having a high number of mutations compared to previous variants.

Newswise: UCLA Health Taps Dr. Priscilla Hsue as Chief of the Cardiology Division
Released: 14-Mar-2024 2:30 PM EDT
UCLA Health Taps Dr. Priscilla Hsue as Chief of the Cardiology Division
University of California, Los Angeles (UCLA), Health Sciences

The UCLA Department of Medicine is pleased to announce that Priscilla Hsue, MD will be joining us as the chief of the Division of Cardiology at UCLA, effective July 1, 2024.

Released: 14-Mar-2024 1:15 PM EDT
New Tuberculosis Test Could Improve TB Care Globally by Increasing Access to Testing in Low- and Middle-Income Countries
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A new tuberculosis (TB) test disclosed in the Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) Clinical Chemistry journal would allow testing for TB treatment monitoring to occur outside of a biosafety level 3 (BSL-3) laboratory.

Released: 14-Mar-2024 11:05 AM EDT
Measles 2024: What You Need to Know
RUSH

Measles cases are being reported in different parts of the United States. David Nguyen, MD, a RUSH infectious disease physician who treats adults and children, answers the most common questions about the measles virus.

Newswise: Mount Sinai Establishes Department of Public Health
12-Mar-2024 9:30 AM EDT
Mount Sinai Establishes Department of Public Health
Mount Sinai Health System

Rosalind J. Wright, MD, MPH, appointed inaugural Dean for Public Health and Chair of the new Department of Public Health to spearhead a state-of-the-art curriculum in public health research, education, and practice that will systematically integrate with medicine, population health, global health, neurosciences, environmental medicine, data science and Artificial Intelligence (AI) disciplines.

Not for public release

This news release is embargoed until 4-Mar-2024 5:00 PM EST Released to reporters: 27-Feb-2024 2:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 4-Mar-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 1-Mar-2024 10:05 AM EST
Cleveland Clinic Researchers Uncover How Virus Causes Cancer, Point to Potential Treatment
Cleveland Clinic

Cleveland Clinic researchers have discovered a key mechanism used by Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), to induce cancer. The research points to effective new treatment options for KSHV-associated cancers, including Kaposi’s sarcoma, primary effusion lymphoma, and HHV8-associated multicentric Castleman disease.

Released: 29-Feb-2024 4:05 PM EST
Microbial viruses act as secret drivers of climate change
Ohio State University

In a new study, scientists have discovered that viruses that infect microbes contribute to climate change by playing a key role in cycling methane, a potent greenhouse gas, through the environment.



close
15.90872